Growth Metrics

Baxter International (BAX) Common Equity (2016 - 2025)

Baxter International (BAX) has disclosed Common Equity for 17 consecutive years, with $6.1 billion as the latest value for Q4 2025.

  • Quarterly Common Equity fell 11.99% to $6.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 billion through Dec 2025, down 11.99% year-over-year, with the annual reading at $6.1 billion for FY2025, 11.99% down from the prior year.
  • Common Equity for Q4 2025 was $6.1 billion at Baxter International, down from $7.2 billion in the prior quarter.
  • The five-year high for Common Equity was $9.1 billion in Q4 2021, with the low at $5.6 billion in Q3 2022.
  • Average Common Equity over 5 years is $7.6 billion, with a median of $7.8 billion recorded in 2024.
  • Peak annual rise in Common Equity hit 46.37% in 2023, while the deepest fall reached 36.75% in 2023.
  • Over 5 years, Common Equity stood at $9.1 billion in 2021, then tumbled by 35.37% to $5.9 billion in 2022, then soared by 43.65% to $8.5 billion in 2023, then fell by 17.76% to $7.0 billion in 2024, then decreased by 11.99% to $6.1 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $6.1 billion, $7.2 billion, and $7.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.